Are intravitreal bevacizumab and ranibizumab effective in a rat model of choroidal neovascularization? [electronic resource]
Producer: 20090413Description: 171-7 p. digitalISSN:- 1435-702X
- Angiogenesis Inhibitors -- pharmacology
- Animals
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Humanized
- Aptamers, Nucleotide -- pharmacology
- Bevacizumab
- Choroidal Neovascularization -- drug therapy
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Fluorescein Angiography
- Injections
- Light Coagulation
- Macular Degeneration -- drug therapy
- Ranibizumab
- Rats
- Rats, Inbred BN
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Vitreous Body
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.